BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38528456)

  • 1. ROAR-A: re-optimization based Online Adaptive Radiotherapy of anal cancer, a prospective phase II trial protocol.
    Storm KS; Åström LM; Sibolt P; Behrens CP; Persson GF; Serup-Hansen E
    BMC Cancer; 2024 Mar; 24(1):374. PubMed ID: 38528456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Online adaptive radiotherapy of anal cancer: Normal tissue sparing, target propagation methods, and first clinical experience.
    Åström LM; Behrens CP; Storm KS; Sibolt P; Serup-Hansen E
    Radiother Oncol; 2022 Nov; 176():92-98. PubMed ID: 36174846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: Initial experience and dosimetric benefits.
    Åström LM; Behrens CP; Calmels L; Sjöström D; Geertsen P; Mouritsen LS; Serup-Hansen E; Lindberg H; Sibolt P
    Radiother Oncol; 2022 Jun; 171():37-42. PubMed ID: 35358605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer.
    de Jong R; Visser J; van Wieringen N; Wiersma J; Geijsen D; Bel A
    Radiat Oncol; 2021 Jul; 16(1):136. PubMed ID: 34301300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Online adaptive radiotherapy for muscle-invasive bladder cancer: results of a pilot study.
    Foroudi F; Wong J; Kron T; Rolfo A; Haworth A; Roxby P; Thomas J; Herschtal A; Pham D; Williams S; Tai KH; Duchesne G
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):765-71. PubMed ID: 20932678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
    Qin A; Sun Y; Liang J; Yan D
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of PTV margins for elective pelvic lymph nodes in online adaptive radiotherapy of prostate cancer patients.
    Brennsæter JA; Dahle TJ; Moi JN; Svanberg IF; Haaland GS; Pilskog S
    Acta Oncol; 2023 Oct; 62(10):1208-1214. PubMed ID: 37682727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Online-Onboard Adaptive Intensity-Modulated Radiation Therapy or Volumetric-Modulated Arc Radiotherapy With Image-Guided Radiotherapy for Patients With Gynecologic Tumors in Dependence on Fractionation and the Planning Target Volume Margin.
    Guberina M; Santiago Garcia A; Khouya A; Pöttgen C; Holubyev K; Ringbaek TP; Lachmuth M; Alberti Y; Hoffmann C; Hlouschek J; Gauler T; Lübcke W; Indenkämpen F; Stuschke M; Guberina N
    JAMA Netw Open; 2023 Mar; 6(3):e234066. PubMed ID: 36947038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy for prostate cancer - Does daily image guidance with tighter margins improve patient reported outcomes compared to weekly orthogonal verified irradiation? Results from a randomized controlled trial.
    Tøndel H; Lund JÅ; Lydersen S; Wanderås AD; Aksnessæther B; Jensen CA; Kaasa S; Solberg A
    Radiother Oncol; 2018 Feb; 126(2):229-235. PubMed ID: 29398152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Online adaptive radiotherapy for bladder cancer using a simultaneous integrated boost and fiducial markers.
    Azzarouali S; Goudschaal K; Visser J; Hulshof M; Admiraal M; van Wieringen N; Nieuwenhuijzen J; Wiersma J; Daniëls L; den Boer D; Bel A
    Radiat Oncol; 2023 Oct; 18(1):165. PubMed ID: 37803392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (≤70 Gy) With Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder Cancer.
    Hafeez S; Warren-Oseni K; McNair HA; Hansen VN; Jones K; Tan M; Khan A; Harris V; McDonald F; Lalondrelle S; Mohammed K; Thomas K; Thompson A; Kumar P; Dearnaley D; Horwich A; Huddart R
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1022-30. PubMed ID: 27026308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) - a prospective, randomized, 2-armed phase-II-trial.
    Arians N; Häfner M; Krisam J; Lang K; Wark A; Koerber SA; Hommertgen A; Debus J
    BMC Cancer; 2020 Jan; 20(1):52. PubMed ID: 31964381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target volume motion during anal cancer image guided radiotherapy using cone-beam computed tomography.
    Brooks CJ; Bernier L; Hansen VN; Tait DM
    Br J Radiol; 2018 May; 91(1085):20170654. PubMed ID: 29393674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Image-guided radiotherapy contribution and patient setup for anorectal cancer treatment].
    Masson I; Delpon G; Vendrely V
    Cancer Radiother; 2018 Oct; 22(6-7):622-630. PubMed ID: 30143462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
    Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
    Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
    Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric and feasibility evaluation of a CBCT-based daily adaptive radiotherapy protocol for locally advanced cervical cancer.
    Branco D; Mayadev J; Moore K; Ray X
    J Appl Clin Med Phys; 2023 Jan; 24(1):e13783. PubMed ID: 36208134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients.
    De Bari B; Jumeau R; Bouchaab H; Vallet V; Matzinger O; Troussier I; Mirimanoff RO; Wagner AD; Hanhloser D; Bourhis J; Ozsahin EM
    Acta Oncol; 2016 Jun; 55(6):767-73. PubMed ID: 27034083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring.
    Lee YYD; Nguyen DT; Moodie T; O'Brien R; McMaster A; Hickey A; Pritchard N; Poulsen P; Tabaksblat EM; Weber B; Worm E; Pryor D; Chu J; Hardcastle N; Booth J; Gebski V; Wang T; Keall P
    BMC Cancer; 2021 May; 21(1):494. PubMed ID: 33941111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial.
    Ma TM; Lamb JM; Casado M; Wang X; Basehart TV; Yang Y; Low D; Sheng K; Agazaryan N; Nickols NG; Cao M; Steinberg ML; Kishan AU
    BMC Cancer; 2021 May; 21(1):538. PubMed ID: 33975579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.